Parkinson's disease (PD) is the second most common neurodegenerative disorder after Alzheimer's disease. 1 The etiology of PD is still unknown, and it seems the result of the interplay of genetic and environmental factors.
Residential exposure to air pollution and incidence of Parkinson's disease in a large metropolitan cohort It includes all residents on the census reference day (21 October 2001) who were not living in institutions (prisons, hospitals, or nursing homes). Data were available on gender, age, birthplace, marital status, education, and occupation. Through a record linkage with Municipal Register data, using a personal identifier under strict control to protect individual privacy, data were available on residential history from 1996. In addition, the date in which the subject started to live at the baseline address was available. Vital status was available as of 31 December 2013. We followed the subjects of the cohort for the specific period from 1 January 2008 to 31 December 2013 because the database of pharmaceutical prescriptions (see below) were available only since 2006. We selected subjects free from Parkinson's disease (see below), who are 50+ years of age at inclusion or who turned 50 during the follow-up period (2008) (2009) (2010) (2011) (2012) (2013) . We followed the subjects until 31 December 2013, or 100 years of age, death, migration from Rome, or occurrence of Parkinson's disease, whichever came first.
Sources of health data
We used data from the Regional Health Information System (HIS) which covers both public and private healthcare providers. The HIS includes the Hospital Discharge Registry (HDR), the Exempt from Copays Registry (ECR), and the Regional Drug Registry (RDR) database. The HDR collects discharge data from all hospitals with up to six diagnoses and procedural codes International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) for each record. The ECR includes data on all residents who qualified for free healthcare services for specific conditions, for example, disability, chronic diseases including Parkinson's, low income, or old age. The RDR database includes all individual records for each drug prescription dispensed by general practitioners, by hospitals at discharge, and by specialist outpatient clinics. Drugs are identified through the national drug register code, which refers to the International Anatomical Therapeutic Chemical Classification System. Every prescription reports individual patient information and drug-dispensing dates. Each patient had an identification code and was linked to the Rome Longitudinal Study.
Case definition of Parkinson's disease
To identify people affected by PD, we used the HDR, the ECR, and the RDR. From the HDR, we selected all subjects who were hospitalized from 2001 to 2013 with a primary or a secondary diagnosis of PD (ICD-9-CM: 332.0) (note: we excluded a diagnosis of Parkinsonism-ICD-9-CM: 332.1-in any diagnostic position). From the ECR, we selected all subjects registered with the specific PD code (038.332) from 2005 to 2013. Finally, from the RDR, we selected all patients with at least two antiParkinson pharmacy claims in 1 year: levodopa or dopamine agonists (pramipexole, ropinirole, and pergolide) or Catechol-O-methyltransferase inhibitors (entacapone) (see eTable 1; http://links.lww.com/EE/A15 for ATC codes); the RDR was available from 2006 to 2013.
In order to exclude prevalent cases from the analysis of incidence, we excluded subjects identified as PD cases before 2008 and identified new PD cases as those at the first selection in the Regional Information System (HDR, ECR, RDR, whichever came first) starting the 1 January 2008 (to 2013).
Exposure assessment
We used the Land Use Regression (LUR) models developed for the city of Rome within the ESCAPE project to assess exposure to particulate matter (<10 μm: PM 10 , <2.5 μm: PM 2.5 , and 2.5-10 μm: PM 2.5-10 ), PM 2.5 absorbance, and nitrogen oxides (NO x and NO 2 ). 24, 25 The models and the measurement campaigns are described in detail elsewhere. [24] [25] [26] [27] Briefly, during 2010, nitrogen oxides were measured in 40 sites, whereas particulate matter and PM 2.5 absorbance were measured in 20 sites. The sites were chosen to represent the spatial distribution of residential addresses, following a strict protocol. 26, 27 Nitrogen oxides were measured using passive samplers, whereas particulate matter was measured using Harvard impactors. PM 2.5 absorbance, as proxy elemental carbon, 28 was obtained as a result of the transformation of reflectance measurements on PM 2.5 filters, according to the International Standardization Organization. 27 Measurements were taken in three 2-week periods and were averaged using a continuous background monitoring site that operated the entire year to estimate an annual average measure of pollutants' concentration at each site. 24, 25 Several traffic and land use variables were used to predict pollutants' concentrations in the LUR models using strict protocols. The models' R 2 ranged from 71% (PM 2.5 ) to 86% (NO 2 ) and a cross-validated R 2 from 59% (PM 10 ) to 79% (PM 2.5 absorbance). The equations from the LURs were applied to the coordinates of all the residential addresses of the cohort members on 1 January 2008.
We used a chemical dispersion model to estimate daily (8 hours) summer (May to September) ozone exposure. The Flexible Air quality Regional Model, a three-dimensional Eulerian model of the transport and multiphase chemistry of pollutants in the atmosphere, was applied to the city of Rome with a grid resolution of 1 × 1 km, based on the year 2005 measurements (see eFigure 1; http://links.lww.com/EE/A15). 29 We estimated exposure to each pollutant at subjects' address on 1 January 2008.
Statistical analysis
We calculated crude and standardized incidence rates of PD per 100,000 person-years. We used as standard population the 2008 Italian population (www.demo.istat.it) by sex and age group (50-64; 65-74; 75-84; 85+).
To estimate the association between air pollution exposure and the incidence of Parkinson's disease, we used a Cox proportional hazards regression model, with age as the time scale. We tested the proportional hazards assumption using the Schoenfeld test, and we stratified the baseline hazard function by sex, the only variable that did not satisfy the proportionality assumption.
We considered several variables as potential confounders or effect modifiers: sex, age, level of education (primary school, junior high school, high school, and university), marital status (married, single, separated/divorced, and widowed), place of birth (Rome or other places), and a small-area (census block, average 500 inhabitants) index of socioeconomic position (SEP). 30 The small-area index of SEP is a composite indicator based on 2001 census data. Briefly, it was obtained performing a factor analysis using variables that represent various dimensions of deprivation (education, occupation, family composition, housing tenure, and migration). The indicator categorized the census blocks of Rome, according to the quintiles of its distribution, into five levels (very high, high, medium, low, and very low). 30 We estimated hazard ratios (HRs) of the association between each pollutant (PM 10 /m) for PM2.5 absorbance. In addition, to study the shape of the relationship between air pollution exposure and PD incidence, we used splines with 2 knots. 31 To investigate a possible nonlinear association, we performed a likelihood ratio test between the model with and without spline.
To explore the possible effect modification by sex and age, we performed the likelihood ratio test to compare the goodness of fit of the models with or without an interaction term. In addition, we have considered the possibility to use previous cardiovascular disease (CVD) hospital admissions as a possible effect modifier to evaluate whether the effect of air pollution on PD was lower or higher in patients with preexisting CVD; this approach was followed by Chen and colleagues. 15 However, adjusting for CVD, or stratifying for it, could introduce a collider bias. 32, 33 This is due to the fact that exposure to air pollution and smoking are both risk factors for cardiovascular diseases 34, 35 and smoking can also be inversely associated with PD. 36, 37 Therefore, adjusting for cardiovascular diseases (the collider) can induce a false, strengthened, or reversed association between air pollution and PD. 38 Thus, we performed an additional analysis changing the case definition to include subjects who had previous acute cardiovascular events, that is, subjects who had at least one hospitalization for acute myocardial infarction (ICD-9-CM: 410 or 412 in any diagnostic position) or stroke (ICD9-CM: 431, 433. x1, 434, 436, 438 in any diagnostic position) before PD ("PD with CVD hospitalization"). As an alternative case definition, we considered also cases of PD that had at least three cardiovascular drug prescriptions (Antihypertensive, diuretics, β-blocking agents, calcium channel blockers, and agents acting on the reninangiotensin system) in the year before identification of PD ("PD with CVD drug prescriptions").
To investigate the role of different data sources in our results, we performed a sensitivity analysis limiting cases from the HDR only, from the ECR only, and then from the RDR database only, respectively.
The choice of studying the population from 1 January 2008 was driven by the availability of drug prescriptions from 2006. This implicated the selection, as the study population, of subjects included in the Rome Longitudinal Study who were alive and still residents in Rome as of 1 January 2008. This selection could have introduced a selection bias. To investigate this possibility, we used an inverse probability weighting approach. 39, 40 We used a logistic regression model to predict the probability of being alive and resident in Rome on the 1 January 2008 considering the following variables in the model: sex, age, age squared, marital status, educational level, and birthplace. We calculated the weights as the inverse of the probability of being included. We stabilized the weights and we used them in a sensitivity analysis to take into account the different characteristics of the selected population compared with the subjects included in the original Rome Longitudinal Study.
To account for the possible bias due to deaths that occurred before PD onset, we performed a competing risks analysis using the Fine and Grey method, with death as competing event. 41 In addition, we restricted our population to subjects who are 50+ years of age at inclusion and did not include subjects who turned 50 during the follow-up.
To investigate a possible exposure misclassification bias, due to a long latency period for PD onset, we performed a subgroup analysis on long-term residents, that is, subjects who were living at the baseline address since 1986, and a sensitivity analysis using the exposure assessment on 2001 addresses.
Only study participants with complete exposure and confounder information in the main model were included in all analyses. All analyses were conducted using STATA13 (StataCorp. 2013; Stata Statistical Software: Release 13; StataCorp LP, College Station, TX).
Results
After excluding prevalent Parkinson's cases (N = 9,460, 1%), subjects with missing exposures due to lack of geocoding of some addresses (N = 20,170, 2%), and those with information missing on confounders (12 subjects), we selected 1,008,253 subjects. Table 1 shows the characteristics of the study population. It was composed by 443,956 males (44%) and 564,297 females (56%). The mean age of the study population at the beginning of the follow-up was 63 years (SD = 12). During the follow-up, we identified 13,104 new cases of Parkinson's disease, 6 ,222 males and 6,882 females. The majority of the cases (87.5%) were selected from the drug prescriptions data, 10.3% of incident cases were selected from the ECR, and 2.3% of the incident cases were from the Hospital Discharge Registry. The standardized incidence rate (by sex and age) was 298 per 100,000 person-years; it was higher in males than in females, and did not vary across socioeconomic groups of the population. Table 3 shows the association (HRs) between residential exposure to air pollutants and incidence of Parkinson's disease. There was no evidence of association between exposure to PM 10 and incidence of PD. There was some evidence of a negative association between PD incidence and both PM 2.5 and PM 2.5-10 . There was a negative association between traffic-related air pollutants (PM 2.5 absorbance, NO 2 , and NO x ) and the incidence of PD. We found an HR = 0. On the contrary, we found a positive association between exposure to ozone and PD incidence with an HR = 1.02 (95% CI = 1.00, 1.05) for each 10 μg/m 3 increase in O 3 at residence. The association with ozone remained when we considered confounding by NO 2 in the same model (HR = 1.02; 95% CI = 0.99, 1.04, for 10 μg/m 3 increase in O 3 ), although with larger confidence intervals. eFigure 3; http://links.lww.com/ EE/A15 reports the spline curves for those pollutants for which the likelihood ratio test indicated a departure from linearity (O 3 , NO 2 , PM 2.5 absorbance). Table 4 shows the results of the effect modification analyses by sex and age. We found a lower risk of PD for increasing exposure to PM (PM 10 , PM 2.5-10 , PM 2.5 ) in women and not in men. There was no evidence of effect modification by age, nor by educational level and small-area socioeconomic position (not shown).
We found similar results in the additional analyses we made. When we considered 1,513 PD incident cases with cardiovascular conditions (PD with CVD) as the outcome, the association with air pollution exposure was in the same direction of those reported in the main results (see eTable 3; http://links.lww.com/ EE/A15). The results were similar when we analyzed subjects who had at least three prescriptions for drugs for the cardiovascular system during the year before identification of PD (see eTable 4; http://links.lww.com/EE/A15). Similarly, when we selected new cases only from the Hospital Discharge Registry (3,872 new cases during the follow-up), or when we selected new cases using the Regional Drug Registry (12,706 incident cases), or using the Exempt from Copays Registry (1,513 incident cases), we found results comparable to the main analysis (see eTable 5; http://links.lww.com/EE/A15). Moreover, we found similar results when we added in the model an inverse probability weighting to consider possible differences from the source population (see eTable 6; http://links.lww.com/EE/A15). The same we found when we considered possible competing risks (see eTable 7; http://links.lww.com/EE/A15) and subpopulation with only subject 50+ years of age at inclusion (see eTable 8; http://links.lww.com/EE/A15). Similarly, the additional analysis performed on long-term residents (subjects who were living in the baseline address since 1986) showed the same findings (see eTable 9; http://links.lww.com/EE/A15), as those performed using the exposure models at 2001 address (see eTable 10; http://links.lww.com/EE/A15).
Discussion
Although we found a suggestion of a positive association between residential exposure to ozone and incidence of PD, the most striking results of our study were the negative association between long-term exposure to NO 2 , NO x , soot (absorbance of PM 2.5 ), and incidence of Parkinson's disease in the population of Rome. The results were robust after several sensitivity analyses, and the findings suggest that previous cardiovascular diseases do not play a role in the association between air pollution and PD.
The effects of ambient air pollution on mortality and morbidity for cardiovascular diseases, lung cancer, and coronary events are well known. 23, 34, [42] [43] [44] [45] [46] [47] Conversely, only a few studies (see Table 5 for a review) have investigated the possible association between air pollution exposure and Parkinson's disease, making compelling the rationale for the present study. [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] We found a 2% higher risk of Parkinson's disease (95% CI = 1.00, 1.05) for each 10 μg/m 3 increase in ozone exposure. Currently, only three studies have investigated a possible role of ozone exposure. The first study, conducted in North Carolina and in Iowa, suggested a possible association between ozone exposure and PD, 19 although the authors found an association in North Carolina but not in Iowa. The other two studies, both conducted in Taiwan, showed no association between ozone exposure and PD.
14, 16 Animal studies found that ozone exposure is associated with cumulative damage to the brains of rodents, and ozone inhalation seemed to produce impaired nigral cell morphology and loss of dopamine neurons in rats. [48] [49] [50] In humans, ozone activates proinflammatory genes, 51 and both acute and long-term impacts on mortality have been reported. 52, 53 A study in Mexico City found a relationship between exposure to concentrations of air pollutants and neuroinflammation and innate immune responses in crucial brain target anatomical areas in children and young adults, which could have a causative role in Parkinson's disease. 54 One study in Taipei showed that two major traffic-related pollutants impacting these effects were sulfate and ozone. 55 In contrast with our results of a negative association between exposure to particulate matter and PD in women, other studies did not find evidence of an association between PM 10 exposure and PD. Palacios and colleagues 11, 18 followed a prospective cohort of 121,700 female nurses 30-55 years of age, and they found no evidence that exposure to air pollution (PM 10 and PM 2.5 ) is a risk factor for PD and limited evidence for the association between exposure to metals and risk of the disease. Also Liu and colleagues, 10 in their case-control study in the United States, did not observe a statistically significant association between exposure to particulate matter and Parkinson's disease. On the contrary, Kioumourtzoglou and colleagues, 9 in a cohort of subjects living in 50 cities in the northeastern United States, found strong evidence of an association between PM 2.5 exposure and first hospitalization for Parkinson's diseases, HR = 1.08 (95% CI = 1.04, 1.12) per 1 μg/m 3 increase in annual PM 2.5 concentrations, using city-wide annual concentrations. Chen and colleagues, 15 in a cohort of subject in Canada, found an HR = 1.03 (95% CI = 1.02, 1.05) per 3.4 μg/m 3 increase in annual PM 2.5 concentrations. In a nested case-control study in Taiwan, Chen and colleagues 16 found an odds ratio (OR) = 1.01 (95% CI = 1.00, 1.02) per 1 μg/m 3 increase in PM 10 concentrations. Lee and colleagues, 14 in a case-control study in Taiwan, showed a protective association OR = 0.93 (95% CI = 0.90, 0.96) between PM 10 exposure and incidence of Parkinson's diseases. When, in the sensitivity analysis, we considered only first hospitalizations, we could not find any evidence of an association with PM 2.5 (HR = 0.93; 95% CI = 0.85, 1.01). It is worth noting that besides the overall meta-analytic result, among the 50 US cities they considered, the association was negative in three cities, and not statistically significant in 29 locations. 9 While we did not find any association between particulate matter exposure and PD in men, the recent study on male health professionals in the United States 17 found a negative association with hazard ratios below one (HR = 0.98; 95% CI = 0.97, 0.99; for 10 μg/m 3 increase in PM 10 ). Because the mechanisms through which air pollution affects health (inflammation, oxidative stress, etc.) are similar in men and women, 56 we do not have an explanation for the different results we obtained for particulate matter in the two genders.
In contrast to previous case-control studies, 10,12,13 we found a statistically significant negative association between exposure to NO 2 , NO x , and incidence of Parkinson's disease, not explained by the known inverse relationship between ozone and nitrogen oxides. We estimated a 3% decrease in the risk of incidence of Parkinson's (95% CI = 0.96, 0.99) for each 10 μg/m 3 increase in NO 2 and a 3% decrease (95% CI = 0.96, 0.99) for each 20 μg/ m 3 increase in NO x . On the contrary, the studies carried out in Canada, 15 in Taiwan, 16 and in the United States 10 did not find any association with traffic exposure and NO 2 , and a case-control study in Denmark showed a 9% higher risk (95% CI = 3%, 16%) per interquartile range increase in NO 2 exposure. 12 As regards NO x exposure, the Taiwan study did not show any association, 16 while in the Denmark study a positive association was observed (OR = 1.06; 95% CI = 1.02, 1.11, per interquartile range increase). 12 Generally, epidemiological studies on the effects of air pollution find associations with health outcomes for which smoking is an important risk factor (cardiovascular disease, in particular ischemic heart disease, lung cancer, and respiratory disease). In Table 3 Association between long-term air pollution exposure and incidence of Parkinson's disease Table 4 Association between long-term air pollution exposure and incidence of Parkinson's disease Parkinson's disease, however, smoking has been reported as a protective factor. In a systematic review and meta-analysis of PD and cigarette smoking carried out by Breckenridge and colleagues, 36 a protective role of smoking was found in the onset on PD, with an overall relative risk (RR) = 0.41 (95% CI = 0.34, 0.48). Two studies confirmed the protective effect of both active and passive smoking, 37, 57 while one study found a protective effect of active smoking, but did not find evidence of an association for passive smoking. 58 The mechanism of the protective effect of smoking is attributed to the role of nicotine receptors; several studies showed that nicotine reduced the effect of toxic insults and protected against nigrostriatal damage in Parkinsonian monkey, rat, and mouse models. [59] [60] [61] However, given the only modest amount of urinary cotinine levels in passive smokers, there might be other factors, in addition to nicotine, that influence the protective effect of smoke on PD incidence. However, it has been hypothesized that smoking cessation could be part of the preclinical PD, with a decreased responsiveness to nicotine in this phase of the disease. 3 This is the first study that found an inverse association between exposure to nitrogen oxides and the incidence of Parkinson's disease, and similar results were reported by only one study for particulate matter; thus, further research is needed. This work has several strengths. We used a very large cohort to explore the effects of air pollution on the population. We had several individual characteristics, taken from the 2001 census, and we estimated different pollutants (PM 10 , PM 2.5-10 , PM 2 . 5 , PM 2.5 absorbance, NO 2 , NO x , summer O 3 ) at the residential addresses.
This study also has several limitations. We used a cohort based on administrative data, and information on important risk factors for Parkinson's disease such as diet and past occupational exposures was not available. We adjusted for two measures of socioeconomic status: the individual level of education, and the census-block socioeconomic position, which are strongly related to diet and occupation; however, residual confounding cannot be ruled out.
For 6,984 people in this cohort, information about smoking habits was available from an ancillary dataset. 23 We found no statistically significant association between smoking and several pollutants, that is, PM 2.5 , PM 2.5 absorbance, NO 2 , NO x , summer O 3 . We found slightly less risk of being a smoker with increasing level of PM 10 and PM 2.5-10 , but this marginal association is unlikely to affect our results (see eTable 11; http://links.lww. com/EE/A15). We excluded from the study subjects with missing exposure assessment and we considered losses to follow-up those who migrate from Rome in the study period. Since the characteristics of these subjects were similar to those included in the study, it is unlikely we have introduced a bias. We can also exclude a possible attrition bias. 32 In fact, we did not find differences in main characteristics (sex, socioeconomic status, level of education, and exposure to air pollution) between the population at the inclusion of this study (1 January 2008) and the 2001 census cohort of Rome (Rome Longitudinal Study), where the study population derived from. Similar results were found when we added in the model an inverse probability weighting to consider these possible differences.
A possible bias is due to the probable underestimation of identification of Parkinson's disease cases because we used administrative data instead of clinical information. Although health administrative databases in the Lazio region are complete and of good quality, [62] [63] [64] and although we used a combination of multiple sources of data, only cases diagnosed and recorded in administrative databases could be included in our study. Using administrative datasets, we identified the date of pathology onset as the date recorded in the dataset. In PD it is difficult to establish an exact date of onset, and likely we overestimated the number of person-years free from disease. Although we cannot exclude these possible misclassification biases, we believe that these biases would have been nondifferential between the group of high exposed and the group of low exposed to air pollution. An important limitation is the exposure assessment. The prodromal phase of PD can last over 20 years, and we used land use regression models based on air pollution measurement campaigns implemented in 1 year (2010), and a dispersion model for ozone based on 2005 data. However, for nitrogen dioxide, we demonstrated that the spatial distribution of concentrations did not change in Rome over a period of more than 10 years, 65 we can assume that the same phenomenon occurred in the past. For exposure to summer ozone, given the stability of built environment in Rome and its local meteorology, we believe that the spatial distribution of summer ozone is nearly constant over time. To investigate the possible exposure misclassification we analyzed the subgroup of people who did not change their residence address since 1986, obtaining similar findings.
Conclusion
Overall, we found some evidence that long-term exposure to ozone was positively associated with incidence of PD in the population of Rome, while long-term exposure to traffic-related pollutants (PM absorbance and nitrogen oxides) was negatively associated. We were not able to find a plausible explanation of the negative associations based on the data we have and the issue is to be explored in more detail. Because there are few studies on the association between ozone and PD, and only three cohort studies on the topic, further research should explore the association between air pollution and Parkinson's disease in different settings.
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